Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Trial Profile

Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2015

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Cancer metastases; Osteoporosis
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 03 Nov 2010 Status changed from recruiting to discontinued according to ClinicalTrials.gov.
    • 06 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top